NCT03254134View on ClinicalTrials.gov

Comparative Effectiveness and Safety Between Warfarin and Dabigatran

CompletedOBSERVATIONAL
Enrollment

22,490

Participants

Timeline

Start Date

October 20, 2017

Primary Completion Date

October 30, 2017

Study Completion Date

November 3, 2017

Conditions
Atrial Fibrillation
Interventions
DRUG

Warfarin

patients treated with warfarin

DRUG

Dabigatran

patients treated with Dabigatran

Trial Locations (1)

Unknown

Nippon Boehringer Ingelheim Co., Ltd., Tokyo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT03254134 - Comparative Effectiveness and Safety Between Warfarin and Dabigatran | Biotech Hunter | Biotech Hunter